Gamal Wazni Built a Clinic Network by Making the Complicated Feel Local

The first thing to understand about Gamal Wazni’s career is that the white coat and the spreadsheet are not rival costumes. One taught him how to make a decision with a person sitting a few feet away. The other helped him ask whether that decision could be supported, repeated and improved across a growing number of clinics. His story lives in the difficult space between individual judgment and organizational consistency.

Wazni began on the clinical side. He completed a bachelor’s degree at Ferris State University in 1995, earned his medical degree from Ross University in 2003 and then spent three years in a family-medicine residency at Providence Hospital in Southfield, Michigan. Florida’s public physician record marks 2003 as the year he began practicing. The route matters because family medicine is a front-row education in variety. The day does not arrive neatly sorted. People do.

He eventually concentrated on venous and lymphatic medicine, earning certification from the American Board of Venous and Lymphatic Medicine. He also served as a consultant and national physician trainer for Covidien, teaching doctors to use the ClosureFast catheter. That detail is more than a credential in the margin. Training another professional forces tacit skill into words, order and demonstration. A technique that lives only in one pair of hands cannot travel very far.

01 / The practice becomes a platform

The modest front door

In 2014, Wazni established United Vein & Vascular Centers in Florida. A clinic is an admirably concrete business. It has an address. The phone rings. A schedule fills or does not. Equipment must work, staff must know what happens next, and each handoff has consequences. There is nowhere for a theory to hide for long.

The company’s larger idea was to place specialist outpatient services in accessible local settings and support those sites with shared clinical and operational infrastructure. The clinic could remain human-scale while the machinery behind it became more sophisticated. It is the difference between a neighborhood shop and a neighborhood shop with a very serious operating manual.

Growth followed. By November 2022, United Vein operated more than 30 clinical locations across Florida, the Chicago area, Colorado and Arizona. The dots on the map were the visible achievement. Less visible was everything each dot implied: recruiting, credentialing, leases, equipment, scheduling, quality measures, referral relationships and the small mountain of administration required before a clinician can calmly say, “Come in.”

This is where Wazni’s earlier training work looks like a prelude. A national physician trainer learns that expertise does not scale by proclamation. It scales through sequences, checks, demonstrations and feedback. A founder opening multiple sites faces the same puzzle with more moving pieces. The goal is not to make every professional identical. It is to give good judgment a dependable stage.

02 / The deal

Capital enters; the founder stays

On November 29, 2022, healthcare investor Amulet Capital Partners announced that it had acquired United Vein & Vascular Centers. The financial terms stayed private. The leadership decision did not: Wazni and the existing management team would continue running the company. Amulet described the next phase as national expansion, new locations and a wider service mix.

Founder continuity after an acquisition is a revealing choice. Money can finance a build-out, but it cannot download the founder’s accumulated map of why things are done a certain way, which shortcuts are false economies, or where a tidy process breaks against an untidy day. Keeping Wazni at the helm preserved that memory while adding an investor built around healthcare operations.

His language around the deal was telling. He emphasized infrastructure, an operational partner and a national footprint. These are not the romantic nouns of entrepreneurship. Nobody embroiders “infrastructure” on a pillow. Yet infrastructure is what makes ambition survivable. It turns growth from a heroic sprint into work that another team, in another city, can perform on an ordinary Tuesday.

The acquisition also formalized a transition already underway. Wazni’s early public billing was founder and medical director. By the deal announcement, it was founder and CEO. The change in title mirrors the widening problem set. Clinical leadership asks what care should look like. Executive leadership asks what people, capital and systems will allow that standard to persist while the organization grows.

03 / The public translator

A microphone is another clinic door

Wazni has periodically stepped outside the organization to explain its field. In 2018, NewsRadio WFLA featured him in a CEO Spotlight as United Vein’s founder and medical director. In August 2025, he appeared in studio on WFLA’s Bloom, by then introduced as founder and CEO. The formats changed; the translator’s job did not.

That public role fits the arc. Medicine, physician training, company building and television all require a version of the same act: take specialized knowledge and give another person a useful next step. The vocabulary must be accurate without becoming a barricade. On air, there is no time for a conference lecture. In a clinic, there is no appetite for a management seminar. Clarity has to earn its keep quickly.

He also co-authored a 2021 article in Vein Therapy News with Lowell Kabnick and Ali Wazni. The article focused on outcomes, patient engagement and evidence-based practice. It places Wazni not only in the executive narrative of expansion, but inside the professional conversation about how specialized care is delivered and evaluated.

04 / What builders can steal

Scale the method, preserve the encounter

The useful lesson in Wazni’s story is not “become a doctor, then start a clinic chain.” Career advice should usually survive contact with people who have chosen different careers. The portable idea is that a founder’s advantage often begins as tacit knowledge, then becomes valuable only when it can be taught.

First, narrow expertise creates a wedge. Wazni did not begin by promising to reorganize all of American healthcare before lunch. He worked within a defined specialty and built a focused model. A narrow starting point can make standards sharper, training more specific and the customer’s reason to choose clearer.

Second, the customer experience is larger than the technical act. A clinic visit begins before the clinician enters and continues after the person leaves. Scheduling, explanation, waiting, follow-up and billing are not decorative trim. For an operator, they are part of the architecture. A company that wants repeatability must design the whole journey, including the boring bits that are only boring when they work.

Third, capital is most useful when the operating thesis already has a pulse. Amulet arrived after eight years of company building and more than 30 locations. The partnership could point to a functioning model, not merely a handsome slide. Wazni’s own quote framed the investment as fuel for infrastructure and footprint, with the existing leadership continuing the work.

Finally, staying close to the act of explanation matters. His path from clinician to trainer to media guest suggests that communication was not outsourced as the organization expanded. Founders often become abstractions inside their own companies. A camera, a classroom or a clinic room can be a useful antidote. Each demands plain speech and a clear reason for the listener to care.

There is another lesson in the dates. Wazni practiced for more than a decade before founding United Vein, and the company operated for eight years before the Amulet transaction. The sequence resists the fashionable myth that every meaningful venture must appear at internet speed. Clinical credibility accumulated first. The operating model accumulated next. Institutional capital arrived after there was something observable to expand. Patience here was not passive. It was a long apprenticeship in which every stage supplied material for the next one: broad medical training, focused expertise, teaching, a local practice, multiple locations and finally a national brief.

There is an elegant tension at the center of the story. Healthcare is personal; scale is impersonal. One happens face to face, the other in operating reviews and expansion plans. Wazni’s career is an attempt to make the two cooperate. The neighborhood clinic stays small enough to recognize. The system behind it grows large enough to reach another neighborhood.

That is the founder-operator’s real craft: knowing which parts of the experience should be standardized and which must never feel standard. The protocols can repeat. The attention cannot look copied. It is a difficult balance, which is why the work is more interesting than the map.